Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dose Escalation”

6,708 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 6,708 results

Early research (Phase 1)Study completedNCT02919800
What this trial is testing

A Single-dose, Dose-escalation Study of a Long-acting MOD-5014 in Healthy Adult Male

Who this might be right for
Hemophilia A or B With Inhibitors
OPKO Health, Inc. 32
Early research (Phase 1)Looking for participantsNCT06723236
What this trial is testing

MGC028 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsNSCLC AdenocarcinomaCholangiocarcinoma+2 more
MacroGenics 124
Testing effectiveness (Phase 2)Study completedNCT00331136
What this trial is testing

Pyronaridine and Artesunate (3:1) in Children With Acute Uncomplicated Plasmodium Falciparum Malaria

Who this might be right for
Uncomplicated Plasmodium Falciparum Malaria
Medicines for Malaria Venture 60
Testing effectiveness (Phase 2)Looking for participantsNCT05086692
What this trial is testing

A Beta-only IL-2 ImmunoTherapY Study

Who this might be right for
Advanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more
Medicenna Therapeutics, Inc. 115
Early research (Phase 1)Study completedNCT01957007
What this trial is testing

Vantictumab (OMP-18R5) in Combination With Docetaxel in Patients With Previously Treated NSCLC

Who this might be right for
Solid Tumors
OncoMed Pharmaceuticals, Inc. 34
Testing effectiveness (Phase 2)Active Not RecruitingNCT03326336
What this trial is testing

Dose-escalation Study to Evaluate the Safety and Tolerability of GS030 in Subjects With Retinitis Pigmentosa

Who this might be right for
Non-syndromic Retinitis Pigmentosa
GenSight Biologics 10
Very early researchActive Not RecruitingNCT05634707
What this trial is testing

Evaluation of Fluoxetine and Cytotoxic Lysosomal Stress in Glioma (FLIRT)

Who this might be right for
Primary Brain TumorBrain Tumor, Recurrent
Duke University 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT05262400
What this trial is testing

Learn About the Study Medicine (Called PF-07220060 in Combination With PF-07104091) In Participants With Breast Cancer and Solid Tumors

Who this might be right for
Breast CancerSolid Tumors
Pfizer 235
Early research (Phase 1)Study completedNCT01215500
What this trial is testing

Dose Escalation of Hypofractionated Radiation Therapy in Patients With Metastatic Cancer

Who this might be right for
TumorCancerMelanoma+2 more
University of Chicago 63
Early research (Phase 1)Study completedNCT01058707
What this trial is testing

Dose Escalation Study of MLN0128 in Participants With Advanced Malignancies

Who this might be right for
Advanced Solid Malignancies
Millennium Pharmaceuticals, Inc. 198
Early research (Phase 1)UnknownNCT05303844
What this trial is testing

Oncolytic Virotherapy Plus PD-1 Inhibitor for Patients With Refractory Malignant Ascites

Who this might be right for
Refractory Malignant Ascites
Fudan University 25
Early research (Phase 1)Study completedNCT01403792
What this trial is testing

A Safety Study Of A Single Vaginal Administration Of P2G12 Antibody In Healthy Female Subjects

Who this might be right for
Human Immunodeficiency Virus
University of Surrey 11
Early research (Phase 1)Looking for participantsNCT07280936
What this trial is testing

SHR-2906 Injection in Healthy Subjects With a Single Dose and in Obese Patients With Multiple Doses

Who this might be right for
ObesityOverweight
Beijing Suncadia Pharmaceuticals Co., Ltd 124
Early research (Phase 1)Ended earlyNCT05904236
What this trial is testing

Safety and Tolerability of Intravenous Administration of ICVB-1042

Who this might be right for
Patients With Advanced Solid Tumors
IconOVir Bio 17
Testing effectiveness (Phase 2)Study completedNCT01031836
What this trial is testing

Evaluate Safety and Tolerability of IV or SC Dose of MEDI-545 in Patients With Systemic Lupus Erythematosus.

Who this might be right for
Systemic Lupus Erythematosus
AstraZeneca 30
Early research (Phase 1)Ended earlyNCT00996892
What this trial is testing

Safety, Tolerability and Pharmacokinetics of Cobimetinib in Combination With Pictilisib in Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Tumors
Genentech, Inc. 178
Early research (Phase 1)Study completedNCT00110500
What this trial is testing

Clinical Trial of SB-509-0401 in Subjects With Diabetic Neuropathy

Who this might be right for
Diabetic Neuropathy
Sangamo Therapeutics 12
Testing effectiveness (Phase 2)Study completedNCT00333411
What this trial is testing

Double-blind, Randomised, Placebo-controlled Trial Investigating BIRT 2584 XX in Patients With Moderate/Severe Psoriasis

Who this might be right for
Psoriasis
Boehringer Ingelheim 360
Early research (Phase 1)Study completedNCT00316511
What this trial is testing

Study of L-NDDP (Aroplatin) in Patients With Advanced Solid Malignancies or B-Cell Lymphoma

Who this might be right for
MalignanciesB-Cell Lymphoma
Agenus Inc. 21
Very early researchNot Yet RecruitingNCT06546436
What this trial is testing

The Safety and Efficiency of a Single Dose of CARC-101C in Patients With Autoimmune Type 1 Diabetes Mellitus

Who this might be right for
Autoimmune Type 1 Diabetes Mellitus(T1DM)
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 12
Next Page